Skip to main content
Guidance

2 November 2026: Shamonda virus detected in cattle in Great Britain

Updated 19 November 2026

Applies to England, Scotland and Wales

1. Situation

In October 2026, Shamonda virus (SHAV) was detected in cattle at two dairy farms, one located in Powys, Wales and one in Shropshire, England, after samples were collected and tested at APHA laboratories in Weybridge. Affected cattle presented with clinical signs consistent with those described in acute cases in Europe.

2. Background

During 2026, SHAV has been detected in cattle, sheep, goats, alpacas and horses in several European countries. It is an orthobunyavirus of the Simbu serogroup and is closely related to Schmallenberg virus (SBV). SHAV is believed to be transmitted by Culicoides biting midges, the same vector responsible for transmission of SBV and bluetongue virus.

3. Clinical presentation

Based on descriptions of disease in other countries, acute disease has predominantly been described in adult dairy cattle and may affect multiple animals within a herd over a short period. Clinical signs may include:

  • Reduced rumination
  • Lethargy
  • Inappetence
  • Sudden reduction in milk yield
  • Transient fever
  • Diarrhoea/scour

No acute disease has been observed in sheep or goats to date.

Reproductive effects, including return to service and abortion, have been observed in affected herds alongside acute clinical disease.

Congenital abnormalities have been associated with in-utero SHAV infection in calves and lambs. These may include arthrogryposis, torticollis, scoliosis and brain deformities such as hydranencephaly, porencephaly, and cerebellar hypoplasia.

4. Information for vets in England and Wales

If you see cattle, sheep or goats in England and Wales with compatible signs, contact your local surveillance pathology centre to discuss investigation.

APHA is providing free-of-charge SBV and SHAV testing from October 2026 to May 2027 on calves, lambs, kids and cria with arthrogryposis or other congenital musculoskeletal abnormalities. Submit a fresh brain sample (brainstem preferred) and request testing for SBV and SHAV on the submission form.

Please note that: The clinical presentations and signs associated with SHAV are not specific to the virus. Clinical signs may overlap with a number of other diseases, some notifiable, including bluetongue. Suspicion of notifiable disease must be reported. In England, this is by calling 03000 200 301. In Wales contact 0300 303 8268 and in Scotland call 03000 600 704.

4.1 Public health

There is no evidence that SHAV poses a food safety risk. UKHSA has undertaken a rapid risk assessment, and this considers SHAV to present a very low risk to the general population in the UK at the current time. A full assessment is being undertaken by the Human Animal Infection and Risk Surveillance (HAIRS) group.

5. Further information

Message sent from the Surveillance Intelligence Unit SIU@apha.gov.uk